West Pharmaceutical Services | WST - Cash And Equivalent

Stock Price
302.20
Daily Change
-3.96 -1.29%
Monthly
23.28%
Yearly
39.83%
Q2 Forecast
299.61

West Pharmaceutical Services reported $521.4M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Align Technology USD 1B 103.43M Sep/2025
Avanos Medical USD 89.8M 19.3M Dec/2025
Baxter International USD 1.97B 240M Dec/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Cerus USD 15.67M 321K Sep/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Cooper Companies USD 110.6M 14.3M Sep/2025
Dentsply International USD 326M 37M Dec/2025
Haemonetics USD 363.37M 66.94M Dec/2025
ICU Medical USD 307.96M 8.23M Dec/2025
Insulet USD 716.1M 41.3M Dec/2025
Integra LifeSciences USD 235.05M 2.86M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
J&J USD 21.69B 1.98B Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Merit Medical Systems USD 446.4M 53.95M Dec/2025
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 199.28M 17.2M Dec/2025
Quidel USD 169.8M 71.7M Dec/2025
Repligen USD 566.02M 182.73M Dec/2025
Rockwell Medical USD 12.48M 1.09M Jun/2025
Solventum Corp USD 878M 764M Dec/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Terumo JPY 217.16B 12.86B Sep/2025
Utah Medical Products USD 84.27M 2.09M Sep/2025
West Pharmaceutical Services USD 521.4M 269.9M Mar/2026